NFKB2, which is involved in aberrant activation of androgen receptor in prostate cancer cells, might be coregulated by FXR2 and HNRNPA1 proteins based on our motif enrichment analysis (Table S1). The gene discussed is AR; the disease is prostate carcinoma.